Women who have surgery to remove their thymus gland to treat myasthenia gravis (MG) tend to have experienced symptoms earlier in life than men, but waited longer to receive a diagnosis, a study reports. However, after the surgery, called a thymectomy, female patients have higher rates of complete…
Vyvgart (efgartigimod alfa-fcab) may be safer and more effective than intravenous immunoglobulin (IVIG) therapy in elderly people with generalized myasthenia gravis (gMG), a study shows. In elderly Chinese patients with gMG who were positive for antibodies targeting the acetylcholine receptor (AChR), Vyvgart eased symptoms after four and…
Robotic thymectomy is a safe and effective treatment for people with myasthenia gravis (MG), including patient groups that have historically showed poorer outcomes, a study found. Five years after undergoing robotic thymectomy, a minimally invasive surgery to remove the thymus gland, 84% of patients saw their MG…
Epysqli (eculizumab-aagh), a biosimilar of Soliris (eculizumab), is now available in the U.S. to treat adults with generalized myasthenia gravis (gMG) who test positive for antibodies against acetylcholine receptors (AChRs), the most common type of MG-causing antibodies. Besides myasthenia gravis (MG), Epysqli will also be available for…
Problems speaking and swallowing are common among people with myasthenia gravis (MG), but speech-language evaluations and treatment are not carried out as part of routine care for MG patients, a new study by a trio of U.S. researchers has found. Indeed, compared with the general population, individuals with MG…
Get regular updates to your inbox.
